Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis

Background. Pancreatic enzyme replacement therapy is the standard of care for treatment of malabsorption in patients with cystic fibrosis (CF) and exocrine pancreatic insufficiency (PI). Aim. To evaluate efficacy and safety of a new formulation of pancrelipase (Ultrase MT20) in patients with CF and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Konstan, Michael W., Liou, Theodore G., Strausbaugh, Steven D., Ahrens, Richard, Kanga, Jamshed F., Graff, Gavin R., Moffett, Kathryn, Millard, Susan L., Nasr, Samya Z., Siméon, Édith, Spénard, Jean, Grondin, Josée
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2010
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004382/
https://ncbi.nlm.nih.gov/pubmed/21197074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/898193
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge